Disciplined Investors L.L.C. Makes New $684,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Disciplined Investors L.L.C. purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,263 shares of the healthcare conglomerate's stock, valued at approximately $684,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $32,000. Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $40,000. Finally, DecisionPoint Financial LLC grew its position in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after purchasing an additional 62 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 2.9 %

UNH traded down $15.50 on Friday, hitting $524.94. The company had a trading volume of 9,914,705 shares, compared to its average volume of 4,265,626. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market cap of $480.17 billion, a P/E ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62. The company's fifty day moving average price is $509.39 and its 200 day moving average price is $542.82. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on UNH shares. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. KeyCorp reaffirmed an "overweight" rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.